박병탁 기자

Park Pyeongtak

Reporter
Biowatch Team With a background in Business Administration (MBA), I focus on the pharmaceutical and biotech industries. My goal is to select key information and present it in an easily understandable manner.
mail ppt@kormedi.com

Latest Articles

JW Pharmaceutical Files for Phase 3 Trial of Biweekly Obesity Drug Bofanglutide

AbTis Wins U.S. Patent Ruling, Safeguarding Core Rights to AbClick Platform

Moderna’s Landmark mRNA Cancer Vaccine Phase 3 Success Spotlights Korean Biotech Ties

Celltrion Secures Dominant Market Share in Asia Led by Autoimmune and Oncology Biosimilars

Global Asset Managers Expand Holdings in South Korean Pharma and Biotech

Samsung Bioepis Seeks South Korean Approval for Keytruda Biosimilar SB27

[Reporter’s Notebook] Hanmi Group’s Internal Feuds Keep Invoking the ‘Lim Sung-ki Spirit.’ It Must Apply to Everyone

Celltrion Chairman Seo Jung-jin Forgoes Summer Vacation for Global Business Tour Targeting Record Second Half

Previous12345Next